Immunohistochemical detection of p16INK4ain leukoplakia and oral squamous cell carcinoma

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 12, 2013, Pages 2793-2795

  Prakash, Pradyot ^a   Khandare, Muktesh ^a   Kumar, Mohan ^a   Khanna, Rahul ^a   Prakash Singh, Gyan ^a   Nath, Gopal ^a   Kumar Gulati, Anil ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

HPV; Leukoplakia; Oral carcinoma; P16

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEEK MUCOSA; CONTROLLED STUDY; FEMALE; GINGIVA DISEASE; HARD PALATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; LIP CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PALATE DISEASE; PROTEIN EXPRESSION; SOFT PALATE;

EID: 84890496371     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/7720.3882     Document Type: Article

References (25)

1. National Cancer Institute [Internet]. Surveillance Epidemiology and End Results: SEER Stat Fact Sheets: Oral Cavity and Pharynx - [cited 2013 Feb 22]. Available from: http://www.seer.cancer.gov/statfacts/html/oralcav.html#incidence-mortality
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-2917.
3. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res. 2000;6:1702-10.
4. IARC Monographs on the evaluation of carcinogenetic risk to humans tobacco smoking, Lyon. 2002; vol. 83.
5. IARC Monographs on the evaluation of carcinogenetic risk to Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines, Lyon. 2007; vol. 89.
6. IARC Monographs on the evaluation of carcinogenetic risk to humans. Alcohol Consumption and Ethyl Carbamate. Lyon. 2010;vol. 96.
7. IARC Monographs on the evaluation of Betel-quid and Areca-nut Chewing and Some Areca-nut-derived Nitrosamines, Lyon. 2004; vol. 85.
8. Bouda M, Gorgoulis VG, Kastrinakis NG, Giannoudis A, Tsoli E, Danassi-Afentaki D, et al. "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol. 2000; 13:644-53.
9. INK4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001;92:276-84.
10. Tribius S, Ihloff AS, Rieckmann T, Petersen C, Hoffmann M. Impact of HPV status on treatment of squamous cell cancer of the oropharynx: what we know and what we need to know. Cancer Lett. 2011;304:71-9.
11. Lewis JS Jr. p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol. 2012;6:75-82.
12. Gamble M. Hematoxylins and Eosin. In: Bancroft J.D., Gamble M, editors. Theory and Practice of Histological Technique. 6th ed. Endinburgh. Churchill Livingstone; 2008.
13. WHO Certified [Internet]. IARC Screeing group. Oral cancer - [cited 2013 Feb 22]. Available from: http://screening.iarc.fr/oralindex.php.
14. Petersen PE. Oral cancer prevention and control--the approach of the World Health Organization. Oral Oncol. 2009;45:454-60.
15. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002;52:195-215.
16. Löning T, Ikenberg H, Becker J, Gissmann L, Hoepfer I, zur Hausen H. Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol. 1985;84:417-20.
17. de Villiers EM, Weidauer H, Otto H, zur Hausen H. Papillomavirus DNA in human tongue carcinomas. Int J Cancer. 1985;36:575-78.
18. Klussmann JP, Gültekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, Eckel HE, Pfister HJ, Fuchs PG. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol. 2003 Mar;162(3):747-53.
19. INK4a Expression in HPV-16 Positive Cases: An Immunohistochemical Study." ISRN Pathology. 2013 (2013).
20. Dragomir LP, Simionescu C, Mrgritescu C, Stepan A, Dragomir IM, Popescu MR. P53, p16 and Ki67 immunoexpression in oral squamous carcinomas. Rom J Morphol Embryol. 2012; 53(1):89-93.
21. Chen SF, Yu FS, Chang YC, Fu E, Nieh S, Lin YS. Role of human papillomavirus infection in carcinogenesis of oral squamous cell carcinoma with evidences of prognostic association. J Oral Pathol Med. 2012 Jan;41(1):9-15.
22. Reimers N, Kasper HU, Weissenborn SJ, Stützer H, Preuss SF, Hoffmann TK, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer. 2007;12:1731-8
23. Pérez-Sayáns M, Suárez-Peñaranda JM, Gayoso-Diz P, Barros-Angueira F, Gándara-Rey JM, García-García A. p16(INK4a)/CDKN2 expression and its relationship with oral squamous cell carcinoma is our current knowledge enough? Cancer Lett. 2011;306:134-41.
24. Fregonesi PA, Teresa DB, Duarte RA, Neto CB, de Oliveira MR, Soares CP. p16(INK4A) immunohistochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus. J Histochem Cytochem. 2003;51:1291-97.
25. Gupta R, Srinivasan R, Nijhawan R, Suri V, Uppal R. Protein p 16INK4A expression in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of uterine cervix. Indian J Pathol Microbiol. 2010 Jan-Mar;53(1):7-11.